Free Trial
NASDAQ:RMTI

Rockwell Medical Q1 2025 Earnings Report

Rockwell Medical logo
$1.04 -0.01 (-0.48%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$1.07 +0.03 (+2.88%)
As of 09:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rockwell Medical EPS Results

Actual EPS
N/A
Consensus EPS
-$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Rockwell Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
$17.46 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rockwell Medical Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Monday, May 12, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Remove Ads

Rockwell Medical Earnings Headlines

Markets in Chaos? Here’s What to Do.
Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… But here's the thing: reading the news and refreshing your feed won't protect your portfolio. You need a plan. And that's exactly what I shared in this special market briefing:
See More Rockwell Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rockwell Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rockwell Medical and other key companies, straight to your email.

About Rockwell Medical

Rockwell Medical (NASDAQ:RMTI), together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

View Rockwell Medical Profile

More Earnings Resources from MarketBeat